SPR.ASX JLG.ASX HIQ.ASX PHX.ASX SPA.ASX

Spartan Resources Shareholders Approve Scheme of Arrangement

Spartan Resources Ltd (ASX: SPR) has announced that its shareholders have overwhelmingly approved the proposed acquisition by Ramelius Resources Limited (ASX: RMS) through a scheme of arrangement. A whopping 90.3% of eligible Spartan shareholders voted in favor of the Scheme Resolution, with an impressive 96.3% of the votes cast supporting the deal.

Spartan has now applied to the Supreme Court of Western Australia for approval of the Scheme, with a hearing scheduled for July 21, 2025. If the Court gives the green light, the Scheme is expected to be implemented on July 31, 2025, at which point Spartan shareholders will receive $0.25 cash and 0.6957 new Ramelius shares for each Spartan share they hold.

Johns LYNG Group Ltd Agrees to $1.1 Billion Takeover by PEP

In another major deal, Johns Lyng Group (ASX: JLG) has entered into a Scheme Implementation Deed with Sherwood BidCo Pty Ltd, an entity owned by Pacific Equity Partners (PEP). Under the agreement, PEP will acquire 100% of JLG's shares for $4.00 per share, valuing the company at a cool $1.1 billion.

The Scheme Consideration represents a juicy 77% premium to JLG's closing share price prior to PEP's offer, and the Independent Directors have unanimously recommended the deal in the absence of a superior proposal. The transaction is fully funded and subject to limited conditions, including regulatory approvals and shareholder approval.

HITIQ Expands Global Footprint with UK Consumer Market Launch

In other news, HITIQ Limited (ASX: HIQ) is making waves with the launch of its PROTEQT co-branded concussion management system in the UK market. This marks a significant milestone in the company's international expansion strategy, as it taps into the UK's sizable contact sports community.

A key feature of the PROTEQT system is its direct integration with the NHS 111 telehealth service, allowing users to access free medical assessments and guidance. With production capacity for up to 100,000 units in 2026, HITIQ is well-positioned to meet the anticipated demand as its cutting-edge technology gains traction across the UK.

Pharmx Technologies Renews NDSS Agreement, Expands Supplier Network

Pharmx Technologies (ASX: PHX) has been busy on the partnership front, renewing its long-standing agreement with the National Diabetes Services Scheme (NDSS) and securing over 50 new supplier partnerships across Australia and New Zealand.

The NDSS renewal underscores Pharmx's essential role in the healthcare supply chain, while the expanded supplier network enhances the platform's utility and engagement with pharmacies. With a total of more than 170 active suppliers now on the Pharmx network, the company is well-positioned to drive increased transaction volume and order frequency.

However, Pharmx's journey hasn't been without its challenges. The company recently requested a trading halt and was subsequently suspended from ASX quotation, pending the release of a non-market sensitive announcement. Fortunately, the suspension has now been lifted following the announcement of the NDSS agreement renewal, providing investors with confidence in Pharmx's financial stability and future prospects.

Spacetalk Secures $3 Million and Debt Reduction

Rounding out the day's news, Spacetalk Ltd (ASX: SPA) has secured a $3 million investment from its largest shareholder, Thorney Investment Group, in the form of new convertible notes. Additionally, Spacetalk's secured lender, Pure Asset Management, has agreed to convert $1 million of existing debt into convertible notes, further strengthening the company's balance sheet.

The funds will be used to fuel Spacetalk's international expansion, develop a new app ecosystem, and design and develop new hardware. CEO Simon Crowther expressed confidence that the support from Thorney and the lender underlines their belief in Spacetalk's strategy, allowing the company to fund growth while protecting existing shareholders from immediate dilution.